Historical record - last NADAC publication: 1/1/2018
Product Information
TIKOSYN 125 MCG CAPSULE is a brand product labeled by Pfizer Inc., priced at $9.8598 per EA under NDC 00069580061. Its NADAC has been published 129 times since Aug 3, 2016.
The High Outlier badge above means this manufacturer's average price in the dofetilide market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
.125 mg/1
Manufacturer
Pfizer Inc.NDC
00069580061
Classification
Brand
Dosage Form
CAPSULE
Route
ORAL
Last Updated
1/1/2018
Active Ingredients
DOFETILIDEApproval Type
New Drug (NDA)
FDA Application
NDA020931On Market Since
10/1/1999
Pharmacological Classes
Price Statistics
The NADAC for TIKOSYN 125 MCG CAPSULE has been published 129 times since Aug 3, 2016, and over the history we have for it it has risen 29.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $9.8598 per EA |
|---|---|
| All-time high | $9.8598 (Jan 16, 2019) |
| All-time low | $5.6106 (Dec 21, 2016) |
| Median price | $9.0093 |
| Average price | $8.9331 |
| Largest weekly change | +34.1% (Jan 18, 2017) |
| Weeks tracked | 129 |
| Tracking since | Aug 3, 2016 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of TIKOSYN 125 MCG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for TIKOSYN 125 MCG CAPSULE, manufactured by Pfizer Inc., is $9.8598 per EA (NDC 00069580061), effective Jan 16, 2019.
How has the price of TIKOSYN 125 MCG CAPSULE changed over time?
Over the history we have for it, the NADAC for TIKOSYN 125 MCG CAPSULE has risen 29.3%. It has been tracked across 129 weekly CMS publications since Aug 3, 2016.
What are the highest and lowest recorded NADAC prices for TIKOSYN 125 MCG CAPSULE?
Since Aug 3, 2016, the NADAC for TIKOSYN 125 MCG CAPSULE has ranged from a low of $5.6106 (Dec 21, 2016) to a high of $9.8598 (Jan 16, 2019), with a median of $9.0093 per EA.
Are there cheaper alternatives to TIKOSYN 125 MCG CAPSULE?
1 NADAC-published product shares the same active ingredient, strength, and dosage form as TIKOSYN 125 MCG CAPSULE, but none are currently priced below it.
Who manufactures TIKOSYN 125 MCG CAPSULE?
TIKOSYN 125 MCG CAPSULE (NDC 00069580061) is labeled by Pfizer Inc., and CMS classifies it as a brand product.
Related Drugs
Same classification